Healthy.io, which helps patients analyze urine samples with a testing kit and smartphone app, raises $60M Series C led by Corner Ventures
Roughly six years ago, former Israel chief technology officer Yonatan Adiri cofounded Healthy.io, a digital health care startup leveraging AI …
Context & Ripple Effects
Healthy.io's $60M Series C lands in the middle of a funding wave for AI tools that move medical assessment out of the clinic: Your.MD had raised €25M for its Healthily symptom checker in late 2020, Ada Health pulled in a $90M Series B led by Leaps by Bayer, and Karius later raised successive mega-rounds for AI blood-test analysis across 400 hospitals.
What makes this round worth tracking is the arc it closes: four years later, the company raised a $50M Series D while laying off roughly a third of its staff, an early signal that consumer-facing diagnostic apps could raise large rounds before proving durable economics.
First-order effects
- Corner Ventures' lead gives cofounder Yonatan Adiri fresh capital to push smartphone-plus-kit urine testing toward mainstream patients, positioning Healthy.io against the clinic-bound lab model rather than against other app-based triage players like Ada Health.
Second-order effects
- Investor appetite validated here spills into adjacent at-home diagnostics: Karius's later $100M Khosla-led round for AI blood-test analysis shows the same thesis migrating from urine kits to hospital-grade testing.
Third-order effects
- If the pattern holds, diagnostics splits into two tracks — venture-funded consumer self-testing and reimbursed clinical AI — and Healthy.io's eventual downsizing suggests the consumer track faces a reckoning on retention and payer coverage once the cheap-capital era ends.
The trend: Capital is flowing into AI startups that relocate diagnostics from labs and clinics to the patient's phone, but Healthy.io's later layoffs show the funding cycle running ahead of sustainable unit economics.